" Development of Primary Cultures of Diaphragmatic Myoblasts for Basic Research Purposes "
- Sponsor
- Assistance Publique - Hôpitaux de Paris
- Study ID
- NCT07380308
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
Eligibility Criteria
- Sex
- FEMALE
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- During the surgery planned as part of the routine care of the patient, a part of the tissue sample will be saved in order to carry out the analysis planned for the research. — OTHERDuring the surgery planned as part of the routine care of the patient, a part of the tissue sample will be saved in order to carry out the analysis planned for the research.
Study Details
Neuromuscular diseases (NMDs) affecting motor neurons (MN) induce progressive muscle denervation, and become fatal when respiratory muscles e.g. the diaphragm are affected and can no longer contract. In some cases, such as Charcot's disease (Amyotrophic lateral sclerosis-ALS), there is no cure and patients die due to respiratory failure few years after diagnosis. Investigations on NMD-induced alterations of respiratory muscles in humans are limited notably by the absence of available in vitro model based on cell cultures of diaphragm-derived myoblasts. Yet, this cell tool is likely to help in developing original therapies to limit diaphragm muscle atrophy and dysfunction in NMD. To date, only cell cultures of human myoblasts obtained from limb muscles are available, making difficult to transpose results to the diaphragm. Thus, in the present project, we propose to : 1. originally develop primary cultures of myoblasts from human diaphragm, obtained from surgical resection of diaphragmatic endometriosis, 2. characterize them in terms of differentiation status (Histology, IF), metabolism (Metabolomics by NMR, cell respiration), and gene expression (RNASeq), in comparison to primary myoblasts cultures derived from the deltoid already available in the team. This project will provide an original new tool and important data on the specificity of diaphragm-derived myoblasts, compared to limb muscle-derived myoblasts with the long-term perspective of opening new therapeutical pathways for patients with severe NMDs.
Key Dates
- First listed
- Feb 2, 2026
- Start date
- Feb 1, 2026
- Status verified
- Jan 2026
- Primary completion
- Apr 1, 2026
- Completion
- May 1, 2026
Study Design
- Enrollment
- 10 participants (estimated)
Arms
- Arm: PatientsPatients with endometriosis requiring surgical nodules resection in the diaphragm.
Primary Outcome Measure
Molecular characteristics [ Time Frame: Inclusion ]
Central Contacts
- Christelle NGUYEN, MD, PHD00 33 1 58 41 29 45
- Marie BENHAMMANI-GODARD0033158411190
Find similar trials
Related Studies
- Cardiovascular Disease Risk in Women With EndometriosisEARLY_PHASE1 · Recruiting · Yale University · New Haven, Connecticut
- Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation ResearchRecruiting · Brain Inflammation Collaborative · Delafield, Wisconsin
- Endometriosis and Microvascular Dysfunction; Simvastatin and DuaveePHASE4 · Recruiting · Penn State University · New Haven, Connecticut
- Endometriosis and Microvascular Dysfunction: Role of InflammationEARLY_PHASE1 · Recruiting · Penn State University · University Park, Pennsylvania